AZN three-lens brief
Evidence-based stock research on AZN. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 10.8pp over 30 days. · Debt-to-equity of 71.8 — balance-sheet-heavy.
- Underperforming SPY by 10.8pp over 30 days.
- Analyst mean target $223.79 — 21% above current (10 analysts).
- Debt-to-equity of 71.8 — balance-sheet-heavy.
AZN closed at $184.44 (-0.16%) as of 2026-05-04. Market cap: $285.93B. P/E (trailing) 27.8. Positives: analyst mean target $223.79 — 21% above current (10 analysts).. Concerns: underperforming SPY by 10.8pp over 30 days.; debt-to-equity of 71.8 — balance-sheet-heavy.. Last quarter: Revenue $15.29B, net income $3.08B, free cash flow $6.54B.
Why three lenses on AZN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AZNacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AZN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AZN brief"></iframe>